BofA lowered the firm’s price target on Walgreens Boots Alliance to $22 from $23 and keeps an Underperform rating on the shares ahead of the company’s fiscal Q2 earnings report due on Thursday. With the focus “squarely on” the company’s evolving strategy under newly appointed CEO Tim Wentworth, the biggest longer term question is what the future asset base of the company will look like and how Walgreens would look to deploy capital from any sales, the analyst tells investors in a preview note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Walgreens Boots Alliance Inc. (WBA) Q2 Earnings Cheat Sheet
- Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
- Walgreen Boots call volume above normal and directionally bullish
- Walgreens Boots Alliance price target lowered to $22 from $23 at Leerink
- Unusually active option classes on open March 15th
